OMER NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Omeros Corporation · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 11.84 USD
20.9% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 4.3% above the Trend Line and sits at 59.1% of its 52-week range. The latest completed week returned 20.9%, after a 27.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 52/100 conviction, while the latest news-sentiment score is 46/100. Near-term considerations: earnings are due in 12d.

Setup score 51 out of 100
Latest Close 11.84 USD 31 Jul 2026
1W Return 20.9% latest completed week
4W Return 27.6% short-term follow-through
12W Return -16.2% quarterly tape
Trend Breadth 59.6% 31 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is negative, which weakens the current setup.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 20.9% Latest completed week; four-week move 27.6%. Indicator stack 33/32 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 52/100 conviction; expected move 29.9%. News sentiment 46/100 59 relevant articles in the latest sentiment read. Event risk 12d Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 4.3% above the Trend Line and sits at 59.1% of its 52-week range. The latest completed week returned 20.9%, after a 27.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1612-week average 0.41

12-week confirmation

Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.16Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 27.6% over four weeks, -16.2% over 12 weeks, and 228.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W20.9%
4W27.6%
12W-16.2%
26W1.3%
52W228.0%
Active trend streak0 weeks
Active weeks in one year31
Trend breadth59.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.94Latest activity-pressure read.
Pressure change-8.7%Four-week change in activity pressure.
Leadership13.24Latest relative-leadership reading.
RS change226.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength47/100Blend of value, momentum, and quality. Underlying universe rank 54; rank 1 is best.
Value48/100Relative valuation strength. Underlying universe rank 53; rank 1 is best.
Quality47/100Profitability and accounting quality. Underlying universe rank 54; rank 1 is best.
Momentum48/100Medium-term price momentum. Underlying universe rank 53; rank 1 is best.
Growth48/100Revenue and earnings growth. Underlying universe rank 53; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework82/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
8.2x
Price divided by trailing earnings.
Price / sales
71.6x
Market value relative to trailing revenue.
EV / EBITDA
11.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-9.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
929.8%
Operating profit retained from revenue.
Free-cash-flow margin
-957.6%
Free cash flow generated from revenue.
Return on invested capital
36.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-5.0%
Net share repurchases relative to market value.
Shareholder yield
-5.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

OMER shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.15, expected move of 29.9%, and Sharemaestro trend signal inactive.

Conviction52/100
Expected move29.9%
Put/call volume0.15
Pressure81
Speculation41
Volatility96
Trend agreement0
Open options detail
Insider activity11 / 2

11 acquisitions and 2 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment46/100

Weighted news tone is neutral across 59 relevant articles.

13 positive · 33 neutral · 13 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings12dNext report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
Options expected move29.9%Nearest-chain priced movement where available.
52-week drawdown-32.9%Distance below the 52-week high.
13-week volatility11.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+20.9%Week of 31 Jul.
Worst week-15.7%Week of 26 Jun.
Latest week+20.9%Week of 31 Jul.

Shape of recent returns

Strong gains9
Modest gains4
Flat weeks0
Modest losses4
Sharp losses9
Recent vol11.4%13-week weekly-return volatility.
Base vol17.8%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew13.7% / -6.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape44/100

Trend, activity pressure, participation, and risk combine to a 44/100 tape read.

 Indicator analysis29/100

Latest 12-week confirmation: trend 3/12, activity pressure 3/12, relative leadership 4/12.

Activity pressure 0.16; No reversal markers Factors46/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 82; Small Cap Core rank 55 SVQF82/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 131.0 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options36/100

OMER shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.15, expected move of 29.9%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 29.9% Sentiment46/100

Weighted news tone is neutral across 59 relevant articles.

Omeros Corporation Revenue Breakdown – HAM:3O8 Insiders11 / 2

11 acquisitions and 2 disposals in the latest 180-day insider tape.

 Earnings12d

Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202611.84 USD20.9%11.35 USD6.42 USD-0.9413.249.9MOff
24 Jul 20269.79 USD1.0%11.50 USD6.37 USD-1.12-4.575.6MOff
17 Jul 20269.69 USD-5.7%11.70 USD6.33 USD-0.97-6.147.1MOff
10 Jul 202610.28 USD10.8%11.69 USD6.30 USD-0.87-3.586.4MOff
3 Jul 20269.28 USD7.0%11.69 USD6.27 USD-0.87-10.507.5MOff
26 Jun 20268.67 USD-15.7%11.74 USD6.25 USD-0.83-14.8516.0MOff
19 Jun 202610.28 USD17.7%11.77 USD6.23 USD-0.72-2.748.6MOff
12 Jun 20268.73 USD-10.8%11.73 USD6.20 USD-0.60-14.2513.2MOff
5 Jun 20269.79 USD-11.3%11.70 USD6.18 USD-0.31-0.928.7MOff
29 May 202611.04 USD-3.7%11.59 USD6.16 USD0.017.709.3MOn
22 May 202611.46 USD-6.4%11.47 USD6.14 USD0.3016.487.0MOn
15 May 202612.25 USD-13.3%11.34 USD6.10 USD0.4627.7711.0MOn
8 May 202614.13 USD-6.2%11.20 USD6.06 USD0.4549.254.0MOn
1 May 202615.06 USD11.3%10.87 USD6.01 USD0.1169.586.4MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.